Table 1.
Ocular concomitant medications
Ocular concomitant therapy/indication | Placebo (n = 120) | Visomitin (n = 120) | ||
---|---|---|---|---|
Treatment period | Follow-up period | Treatment period | Follow-up period | |
Lubricant/dry eye | 0 | 6 | 0 | 2 |
Keratoprotector/dry eye | 1 | 1 | 0 | 1 |
Antioxidants/AMD | 0 | 0 | 1 | 1 |
AMD age-related macular degeneration